Genotyping on a Thermal Gradient DNA Chip

  1. Tomoharu Kajiyama1,2,
  2. Yuji Miyahara2,
  3. Larry J. Kricka3,
  4. Peter Wilding3,
  5. David J. Graves4,
  6. Saul Surrey5, and
  7. Paolo Fortina1
  1. 1Department of Pediatrics, The Children's Hospital of Philadelphia and University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA; 2Hitachi High-Technologies Corporation, Hitachinaka-shi, Ibaraki-ken, 312-8504 Japan; 3Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA; 4Department of Chemical Engineering, University of Pennsylvania School of Engineering and Applied Science, Philadelphia, Pennsylvania 19104, USA; 5Cardeza Foundation for Hematologic Research, Department of Medicine, Jefferson Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania 19107, USA

Abstract

Silicon-based chips with discrete, independently temperature-controlled islands have been developed for use in DNA microarray hybridization studies. Each island, containing a heater made of a diffusion layer and a temperature sensor based on a p–n junction, is created on a silicon dioxide/nitride surface by anisotropic etching. Different reactive groups are subsequently added to the surface of the islands, and allele-specific oligonucleotide probes are attached to discrete spots on the chip. Hybridization is performed with Cy5-tagged single-stranded targets derived by PCR from genomic DNA. Results are assessed by measuring fluorescence of bound dye-tagged targets after hybridization and washing. Temperatures at each island can be set at different values to obtain optimal distinction between perfect matches and mismatches. This approach facilitates definition of optimal temperatures for probe/target annealing and for distinction between perfectly matched versus mismatched solution-phase targets. The thermal gradient DNA chips were then tested for genotyping, and the results for four different loci in two genes are presented. Unambiguous typing was achieved for clinically relevant loci within the factor VII and hemochromatosis genes.

Footnotes

  • 1 Corresponding author.

  • E-MAIL paolo.fortina{at}mail.tju.edu; FAX (215) 503-2803.

  • Article and publication are at http://www.genome.org/cgi/doi/10.1101/gr.790603.

    • Received September 10, 2002.
    • Accepted December 6, 2002.
| Table of Contents

Preprint Server